ABBOTT LABORATORIES lobbying for ABBOTT LABORATORIES

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$1,750,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

BETH NELSON New on this filing

Previously held: Health Policy Dir - Sen T Young Sr Health Policy Advisor - HELP Sr Policy Advisor - Sec of HHS Leg Asst - Sen J Cornyn Health Policy Advisor - Rep S Johnson Sr Leg Asst - Rep D Reichert Sr Leg Asst - Rep S Austria Sr Leg Asst - Rep D Hobson
MATTHEW APPLE New on this filing

Previously held: Staff Asst - Speaker P Ryan Special Asst to Sec - Sec Azar (HHS) Policy Advisor to Sec HHS Leg Aide - Sen Hagerty Leg Asst - Rep. Letlow

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 7

Agriculture, Dept of (USDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
State, Dept of (DOS)
U.S. Trade Representative (USTR)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 6

S 2477
Equitable Community Access to Pharmacist Services Act
HR 1770
Equitable Community Access to Pharmacist Services Act
S 1000
Saving Access to Laboratory Services Act
HR 1835
Saving Access to Laboratory Services Act
HR 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
S 3387
Ensuring Safe and Toxic-Free Foods Act of 2023

Lobbying activity 6

Health Issues

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to telehealth implementation and remote monitoring. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

Medicare/Medicaid

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

Trade (domestic/foreign)

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.

Agriculture

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

Taxation/Internal Revenue Code

Proposals to reform domestic and international tax structures.

Food Industry (safety, labeling, etc.)

S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023.